医学临床研究
  2025年4月7日 星期一           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2023, Vol. 40 Issue (8): 1128-1131    DOI: 10.3969/j.issn.1671-7171.2023.08.003
  论著 本期目录 | 过刊浏览 | 高级检索 |
血清T淋巴细胞亚群及PLR、MLR、NLR对尿毒症腹膜透析相关性腹膜炎患者的预测价值
李怡素a, 贺雪b, 徐勇a, 刘骏a, 胡静a, 刘纪实a**
中南大学湘雅三医院:a.肾内科;b.健康管理中心,湖南 长沙 410013
The Predictive Value of Serum T Lymphocyte Subsets,PLR,MLR and NLR for Peritoneal Dialysis Peritonitis
LI Yi-su, HE Xue, XU Yong, et al
Department of Nephrology,the Third Xiangya Hospital of Central South University,Changsha Hunan 410013
全文: PDF (1289 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨血清T淋巴细胞亚群及中性粒细胞/淋巴细胞比值(neutrophil-to-lym-phocyteratio,NLR)、淋巴细胞/单核细胞比值(lymphocyte-to-monocyte ratio,MLR)、血小板/淋巴细胞比值(platelet-to-lymphocyte ratio,PLR)对尿毒症腹膜透析相关性腹膜炎(PDAP)患者的预测价值。【方法】选取2018年3月至2022年3月在本院住院治疗的119例尿毒症腹膜透析(PD)患者,根据是否合并PDAP分为腹膜炎组和非腹膜炎组。比较两组T淋巴细胞亚群(CD4+、CD8+、CD4+/CD8+)、炎症指标水平,分析各指标的相关性及其对PDAP的预测价值。【结果】腹膜炎组CD4+、CD4+/CD8+均高于非腹膜炎组, CD8+、T淋巴细胞计数均低于非腹膜炎组,差异均有统计学意义(P<0.05);两组T淋巴细胞百分比比较,差异无统计学意义(P>0.05);腹膜炎组NLR、MLR、PLR、超敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)、红细胞沉降率(erythrocyte sedimentation rate,ESR)、降钙素原(procalcitonin,PCT)均高于非腹膜炎组,差异均有统计学意义(P<0.05)。CD4+/CD8+与NLR呈负相关(r=-0.327,P<0.05),与MLR、hs-CRP呈正相关(r=0.875、r=0.306,P<0.05)。血清CD4+、CD8+、CD4+/CD8+、PLR、NLR、MLR、hs-CRP、ESR、PCT预测PDAP的曲线下面积(AUC)分别为0.711、0.365、0.700、0.720、0.886、0.931、0.883、0.802、0.737。【结论】血清T淋巴细胞亚群及PLR、MLR、NLR、hs-CRP、ESR、PCT对PDAP均具有较好的预测价值,其中NLR、MLR特异性最强,具有较高的临床参考价值。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 腹膜炎尿毒症腹膜透析T淋巴细胞亚群    
Abstract:【Objective】To investigate the predictive value of serum T lymphocyte subsets,neutrophil-to-lymphocyte ratio(NLR),monocyte-to-lymphocyte ratio(MLR) and platelet-to-lymphocyte ratio(PLR) ratio for peritoneal dialysis-associated peritonitis (PDAP)diagnosis. 【Methods】A total of 119 peritoneal dialysis-associated patients who were hospitalized in our hospital from March 2018 to March 2022 were enrolled and divided into the peritonitis group and non-peritonitis group. The differences and correlations of T lymphocyte subsets (CD4+,CD8+,CD4+/CD8+) and various inflammatory indicators in each group were compared,and their predictive value for peritoneal dialysis peritonitis was analyzed. 【Results】The CD4+ and CD4+/CD8+ in the peritonitis group were higher than those in the non-peritonitis group,and the differences were statistically significant (P<0.05). CD8+ and T lymphocyte counts in the peritonitis group were lower than those in the non-peritonitis group,and the differences were statistically significant (P<0.05). There was no significant difference in the percentage of T lymphocytes between the two groups (P>0.05).However,NLR,MLR,PLR,hs-CRP,erythrocyte sedimentation rate(ESR) and procalcitonin(PCT) in the peritonitis group were higher than those in the non-peritonitis group,and the differences were statistically significant (P<0.05). The CD4+/CD8+ was negatively correlated with NLR (r=-0.327,P<0.05),positively correlated with MLR (r=0.875,P<0.05),and positively correlated with hs-CRP (r=0.306,P<0.05). The AUC of serum CD4+,CD8+,CD4+/CD8+,PLR,NLR,MLR,hs-CRP,ESR,and PCT in predicting peritoneal dialysis-related peritonitis were 0.711,0.365,0.700,0.720,0.886,0.931,0.883,0.802,and 0.737,respectively. 【Conclusion】Serum T lymphocyte subsets,PLR,MLR,NLR,hs-CRP,ESR and PCT have good predictive value for peritoneal dialysis-associated peritonitis. Of which,NLR and MLR have the strongest specificity and higher clinical reference value.
Key wordsPeritonitis    Uremia    Peritoneal Dialysis    T-Lymphocyte Subsets
收稿日期: 2023-02-27     
中图分类号:  R656.41  
基金资助:湖南省卫生健康委基金(编号:202103050563)
通讯作者: **E-mail:26545559@qq.com   
引用本文:   
李怡素, 贺雪, 徐勇, 刘骏, 胡静, 刘纪实. 血清T淋巴细胞亚群及PLR、MLR、NLR对尿毒症腹膜透析相关性腹膜炎患者的预测价值[J]. 医学临床研究, 2023, 40(8): 1128-1131.
LI Yi-su, HE Xue, XU Yong, et al. The Predictive Value of Serum T Lymphocyte Subsets,PLR,MLR and NLR for Peritoneal Dialysis Peritonitis. JOURNAL OF CLINICAL RESEARCH, 2023, 40(8): 1128-1131.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.08.003     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I8/1128
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn